- Lead the end-to-end strategy and implementation across the digital health solution lifecycle including the definition of concepts, business models and the building of cross-functional delivery teams to address clinical value propositions.
- The Digital Health Leader is a key subject matter expert for Digital Health and provides senior leadership to the Digital Health initiatives and business processes for the assigned TAs within Medical Affairs
- Develops standard processes, guidelines, and tools to accomplish the Digital Health programs, and ensures that the Digital Health programs are performed in a compliant and strategic manner for the assigned TAs
QualificationsRoche is looking for a passionate individual, combining digital health knowledge with business understanding to drive the integration of Digital Health in PDMA and successfully support the GMTs in the optimal implementation of such projects.
In addition, you have the following:
- Professional experience (at least 8 years) in the pharmaceutical/ biotechnology industry or related experience (preferably in positions related to Digital Health and Medical Affairs)
- Experience with all aspects of Digital Health activities, and other medical affairs activities and healthcare professional (HCP) and patient/ patient groups interactions strongly preferred
- Experience as a successful decisive leader in a cross-functional environment adept at managing complex programmes without direct reports
About RocheRoche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.